Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin in Borderline Personality Disorder
NCT02225600Suspended
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Aug 2014
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Randomised trial of oxytocin nasal spray in borderline personality disorder (BPD) (2 arms), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoint: Trust Game Affect Ratings at 4 weeks. Started Aug 2014; status: suspended.
02
Drugs
oxytocin nasal spray
03
Conditions
borderline personality disorder (BPD)
Beyond the preview
Go deeper on NCT02225600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02225600.